In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global (DIDI). The second largest IPO of the year, DiDi (DIDI) upsized and priced at the...read more
CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, raised $126 million by offering 7 million shares at $18, above the range of $15 to $17. The company offered 0.75 million more shares than anticipated. CVRx manufactures...read more
17 IPOs are slated to raise $9.1 billion in the week ahead, led by long-awaited Chinese ride-hailing giant DiDi Global (DIDI).
DiDi (DIDI) plans to raise $3.9 billion at a $67.5 billion market cap. DiDi is China’s...read more
CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, announced terms for its IPO on Wednesday. The Minneapolis, MN-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more
US IPO Weekly Recap: DiDi leads a 19 IPO week, the busiest since 2004
In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global (DIDI). The second largest IPO of the year, DiDi (DIDI) upsized and priced at the...read more
Neuromodulation device maker CVRx prices upsized IPO at $18, above the range
CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, raised $126 million by offering 7 million shares at $18, above the range of $15 to $17. The company offered 0.75 million more shares than anticipated. CVRx manufactures...read more
US IPO Week Ahead: DiDi makes its billion-dollar debut in a 17 IPO week
17 IPOs are slated to raise $9.1 billion in the week ahead, led by long-awaited Chinese ride-hailing giant DiDi Global (DIDI). DiDi (DIDI) plans to raise $3.9 billion at a $67.5 billion market cap. DiDi is China’s...read more
Neuromodulation device provider CVRx sets terms for $100 million IPO
CVRx, which makes a minimally invasive neuromodulation device for cardiovascular disease, announced terms for its IPO on Wednesday. The Minneapolis, MN-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more